International Stem Cell Corporation to Provide Corneal Epithelial Cells Differentiated from Its Parthenogenetic Stem ... (Centre Daily Times)
International Stem Cell (OTCBB:ISCO), www.internationalstemcell.com, announced today that it will be providing corneal epithelial cells, derived from its Parthenogenetic stem cells and human keratinocytes (a type of skin cell), for use in Federal Drug Administration (FDA) clinical trials aimed at creating a tissue transplant technology to improve photorefractive keratectomy (PRK).

Surgeons and Electrophysiologist Publish Positive Data Using AtriCure Minimally Invasive Products (Centre Daily Times)
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, today announced recently published results that report on AtriCure's proprietary minimally invasive products, which physicians have adopted to treat atrial fibrillation (AF). The results were published in the Journal of Interventional Cardiac Electrophysiology by two prominent cardiac ...

FDA Approved Only 19 New Medications In 2007, Analyst Reports (Medical News Today)
FDA in 2007 approved 19 new medications, a decrease from 22 in 2006 and the lowest number since 1983, when the agency approved 14 new treatments, according to Ira Loss of Washington Analysis, Bloomberg/Arizona Daily Star reports. According to Loss, FDA in 2007 approved 17 "new molecular entities" and two biotechnology medications.